Ligature Therapeutics
Biotechnology Research
Singapore, Central Singapore, Sg
6 employees
- Employees
- 6
Ligature Therapeutics Overview
- Headquarters
- Singapore, Central Singapore, Sg
- Industry
- Biotechnology Research
- Employees
- 6
- Founded
- 2020
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Ligature Therapeutics
Ligature Therapeutics (LTx) is an early-stage biotech company generating targeted protein degraders (TPD). LTx is advancing its structure agnostic fragment-based drug discovery platform to generate cancer-selective TPDs, and has achieved early proof of concept with a lead asset. Ligature Therapeutics was an A*STAR (EDDC) spin-off company founded in 2020 with investment from Lightstone Singapore and SEEDS Capital.
Compare Similar Companies to Ligature Therapeutics
Hummingbird Bioscience
Biotechnology Research
Tessa Therapeutics Ltd
Biotechnology Research
Nuevocor
Biotechnology Research
Biotech Connection Singapore
Biotechnology Research
Trinity Innovation Bioventure Singapore
Venture Capital And Private Equity Principals
Axcynsis Therapeutics
Biotechnology Research
Carmine Therapeutics
Biotechnology Research
Singzyme
Biotechnology
NeuroVanda Therapeutics
Biotechnology Research
Lerna Biopharma
Biotechnology Research